TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Traws Pharma, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.37−0.00 (-0.76%)
Close on Oct 19, 2026
- Market cap
- $5.81M
- P/E (TTM)
- 0.4
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Sep 30, 2024 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Sep 23, 2024 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| May 21, 2021 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| May 20, 2021 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Sep 26, 2018 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Sep 25, 2018 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Jun 1, 2016 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| May 31, 2016 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |